Pharma Penny Stock Below Rs 20: Company Receives Order Worth Rs 11,95,31,542.68 from Brihanmumbai Municipal Corporation
The shares of the company have a PE of 13x whereas the industry PE is 35x.
JFL Life Sciences Ltd has announced that it has secured a domestic order from the Brihanmumbai Municipal Corporation. This contract, for the supply of injections and sera vaccines, was received via email on June 30, 2025. The order, valued at Rs 11,95,31,542.68 (including taxes), is for the supply of pharmaceutical/lifecare/healthcare products and is to be executed between June 16, 2025, and June 15, 2027.
Earlier, the company secured a significant order from J D Healthcare, as disclosed per Para B of Part A of Schedule III of the listing Regulations, 2015. This domestic order, detailed in a purchase order dated May 10, 2025, entails the supply of various Pharmaceutical, Lifecare, and Healthcare products. Valued at Rs 12,59,50,000.00, the order is to be executed within nine months from the date of the purchase order, marking a notable development for the company.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
JFL Life Sciences Limited, a WHO-GMP-certified Indian pharmaceutical company established in 2010, manufactures a diverse range of products including dry powder injections, tablets, capsules, and oral rehydration solutions. With a focus on B-Lactam formulations, the company offers over 320 products across various dosage forms. The company has a market cap of Rs 55 crore.
The promoters of the company hold 67.47 per cent and the public owns a 32.53 per cent stake in the company as of June 2025. The shares of the company have a PE of 13x whereas the industry PE is 35x. The stock is up by 25 per cent from its 52-week low of Rs 13.27 per share.
Disclaimer: The article is for informational purposes only and not investment advice.